[go: up one dir, main page]

PE20030693A1 - Tetra-,penta-,hexa- y heptapeptidos con actividad antiangiogenica - Google Patents

Tetra-,penta-,hexa- y heptapeptidos con actividad antiangiogenica

Info

Publication number
PE20030693A1
PE20030693A1 PE2002001060A PE2002001060A PE20030693A1 PE 20030693 A1 PE20030693 A1 PE 20030693A1 PE 2002001060 A PE2002001060 A PE 2002001060A PE 2002001060 A PE2002001060 A PE 2002001060A PE 20030693 A1 PE20030693 A1 PE 20030693A1
Authority
PE
Peru
Prior art keywords
nva
arginyl
ile
arg
heptapeptides
Prior art date
Application number
PE2002001060A
Other languages
English (en)
Inventor
Fortuna Haviv
Michael F Bradley
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/000,711 external-priority patent/US20030105025A1/en
Priority claimed from US10/000,540 external-priority patent/US20030119745A1/en
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of PE20030693A1 publication Critical patent/PE20030693A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1002Tetrapeptides with the first amino acid being neutral
    • C07K5/1005Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

SE REFIERE A UN COMPUESTO DE FORMULA Xaa1-Xaa2-Xaa3-Xaa4-Xaa5-Xaa6-Xaa7-Xaa8 (II) (SEQ ID NO:2) O UNA SAL FARMACEUTICAMENTE ACEPTABLE DEL MISMO DONDE Xaa1 ES H, R-(CH2)nC(O)- DONDE n ES 0-8 Y R ES ALCOXI, ALQUILO, AMINO, ARILO, ENTRE OTROS; Xaa2 ES ß-ALANILO, D-ALANILO, D-ALOISOLEUCILO, D-ALILGLICILO, D-4-CLOROFENILALANILO, D-CITRULILO, ENTRE OTROS; Xaa3 ES ALOTREONILO, ASPARTILO, GLUTAMINILO, D-GLUTAMINILO, N-METILGLUTAMINILO, GLICILO, ENTRE OTROS; Xaa4 ES N-METILALANILO, ALOTREONILO, ARGINILO, GLUTAMINO, D-GLUTAMINO, ENTRE OTROS; Xaa5 ES ALANILO, ALOISOLEUCILO, ASPARTILO, CITRULILO, ENTRE OTROS; Xaa6 ES ARGINILO, D-ARGINILO, CITRULILO, ENTRE OTROS; Xaa7 ES N-METIL-D-ALANILO, 2-AMINOBUTIRILO, ENTRE OTROS; Xaa8 ES D-ALANILAMIDA, AZAGLICILAMIDA, GLICILAMIDA, HIDROXILO, ENTRE OTROS. SON COMPUESTOS PREFERIDOS N-Ac-D-Pro-Thr-Nva-Ile-Arg-ProNHCH2CH3, N-Ac-D-Leu-Thr-Nva-Ile-Arg-ProNHCH2CH3, N-Ac-D-Leu-Ser-Nva-Ile-Arg-ProNHCH2CH3, ENTRE OTROS. LOS COMPUESTOS SON UTILES PARA EL TRATAMIENTO DE ANGIOGENESIS
PE2002001060A 2001-10-31 2002-10-28 Tetra-,penta-,hexa- y heptapeptidos con actividad antiangiogenica PE20030693A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/000,711 US20030105025A1 (en) 2001-10-31 2001-10-31 Tri-and tetrapeptides having antiangiogenic activity
US10/000,540 US20030119745A1 (en) 2001-10-31 2001-10-31 HEXA- and heptapeptides having antiangiogenic activity
US10/263,811 US20030105022A1 (en) 2001-10-31 2002-10-04 Tetra-, penta-, hexa- and heptapeptides having antiangiogenic activity

Publications (1)

Publication Number Publication Date
PE20030693A1 true PE20030693A1 (es) 2003-08-18

Family

ID=32658704

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2002001060A PE20030693A1 (es) 2001-10-31 2002-10-28 Tetra-,penta-,hexa- y heptapeptidos con actividad antiangiogenica

Country Status (3)

Country Link
US (1) US20030105022A1 (es)
AR (1) AR037166A1 (es)
PE (1) PE20030693A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7037897B2 (en) * 2001-10-31 2006-05-02 Abbott Laboratories TRI-, TETRA-, and penta-peptides having antiangiogenic activity

Also Published As

Publication number Publication date
AR037166A1 (es) 2004-10-27
US20030105022A1 (en) 2003-06-05

Similar Documents

Publication Publication Date Title
CA2179286A1 (en) Broad spectrum antimicrobial compounds and methods of use
CL2004001072A1 (es) Compuestos derivados de trifluorofenil-triazolopirimidina; procedimiento de preparacion de los compuestos; compuestos intermediarios utiles como fungicidas.
RU2011115077A (ru) Пептидные антибиотики и способы их получения
ES8301463A1 (es) Procedimiento para la produccion de un polipeptido
ECSP066968A (es) Compuestos de metil-aril o heteroaril-amida sustituida
SV2008002969A (es) Derivados de pirimidina para el tratamiento del crecimiento celular anormal
PE43695A1 (es) Agente antitrombotico peptidico
CO5700783A2 (es) Uso de b7-h3 como un agente inmuno regulatorio
AR036192A1 (es) Peptidos antibioticos con actividad antimicrobiana de amplio espectro y composiciones que los contienen
PE20030693A1 (es) Tetra-,penta-,hexa- y heptapeptidos con actividad antiangiogenica
DK0805685T3 (da) Hidtil ukendte antifungale cyclohexapeptider
CR8275A (es) 2-CARBONILAMINO-6-PIPERIDINAMINOPIRIDINAS SUSTITUIDAS Y 1-CARBONILAMINO-3- PIPERIDINAMINOBENZENOS SUSTITUIDOS COMO 5-HT1f AGONISTAS
MXPA02005139A (es) Peptidos n-alquilados que tienen actividad antiangiogenica.
IL150310A0 (en) Substituted homopiperidinyl benzimidazole analogues as fundic relaxants
PE20030493A1 (es) Hepta-,octa-,y nonapeptidos con actividad antiangiogenica
AR132919A1 (es) Insecticidas de pirazolamida
EA200000762A1 (ru) Способ для консервации органов или других тканей для трансплантации
DK1144421T3 (da) Phosphiniske pseudopeptider, som er inhibitorer af matrix-metalloproteaser
EA200200160A1 (ru) Аналоги псевдомицина с n-ацильной боковой цепью
AU4906799A (en) Substituted benzimidazoles, production and use thereof as agents for combating parasitic protozoas
DK1098878T3 (da) Bispiperidiner som antitrombotiske midler
WO2006108686A3 (en) Bnp agonists
AR029004A1 (es) Compuesto del acido 7-acilamino-3-heteroariltio-3-cefem carboxilico y su uso para la preparacion de una composicion antibacteriana
Green et al. Substrate related O, O-dialkyldipeptidyly ψ carboxybenzylphosphonates, a new type of thrombin inhibitor
DE60328915D1 (de) Verfahren zur herstellung von dem bicyclischen hexapeptide nepadutant

Legal Events

Date Code Title Description
FD Application declared void or lapsed